Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Vella

Showing results (31-40 of 158) with videos related to

Pageof 16
Sort By:
Current Opinion in HIV and AIDS|October 9, 2013
Optimization and simplification of antiretroviral therapy for adults and childrenNathan Ford, Charles Flexner, Stefano Vella, et al.
BMC Pharmacology & Toxicology|September 24, 2013
Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cellsMaria Luisa Dupuis, Alessandro Ascione, Lucia Palmisano, et al.
Lancet (London, England)|September 25, 2023
The EU has a global health strategy: the challenge will be in the implementationMartin McKee, Samantha Field, Stefano Vella, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Mitochondrial membrane hyperpolarization hijacks activated T lymphocytes toward the apoptotic-prone phenotype: homeostatic mechanisms of HIV protease inhibitorsPaola Matarrese, Lucrezia Gambardella, Antonio Cassone, et al.
AIDS (London, England)|June 29, 2016
Unite forces to validate biomarkers in the quest for lasting HIV remissionCasper Rokx, Stefano Vella, Guiseppe Pantaleo, et al.
Pediatrics|August 3, 2004
Italian attention-deficit/hyperactivity disorder registryPietro Panei, Romano Arcieri, Stefano Vella, et al.
BMC Infectious Diseases|September 2, 2024
The safety of a dolutegravir (DTG)-based antiretroviral treatment (ART) regimen for pregnancy and birth outcomes in Ethiopia: evidence from multicenter cohort studyAbel Gedefaw, Birkneh Tilahun Tadesse, Yifru Berhan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 15, 2018
Economic Evaluation of the Hepatitis C Virus Treatment Extension to Early-Stage Fibrosis Patients: Evidence from the PITER Real-World CohortMatteo Ruggeri, Silvia Coretti, Federica Romano, et al.
AIDS (London, England)|June 19, 2012
The history of antiretroviral therapy and of its implementation in resource-limited areas of the worldStefano Vella, Bernard Schwartländer, Salif Papa Sow, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 26, 2002
In vitro and in vivo modulation of MDR1/P-glycoprotein in HIV-infected patients administered highly active antiretroviral therapy and liposomal doxorubicinMothanje Barbara Lucia, Sergio Rutella, Giuseppe Leone, et al.
Pageof 16

Showing results (31-40 of 158) with videos related to

Sort By:
Pageof 16
Current Opinion in HIV and AIDS|October 9, 2013
Optimization and simplification of antiretroviral therapy for adults and childrenNathan Ford, Charles Flexner, Stefano Vella, et al.
BMC Pharmacology & Toxicology|September 24, 2013
Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cellsMaria Luisa Dupuis, Alessandro Ascione, Lucia Palmisano, et al.
Lancet (London, England)|September 25, 2023
The EU has a global health strategy: the challenge will be in the implementationMartin McKee, Samantha Field, Stefano Vella, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Mitochondrial membrane hyperpolarization hijacks activated T lymphocytes toward the apoptotic-prone phenotype: homeostatic mechanisms of HIV protease inhibitorsPaola Matarrese, Lucrezia Gambardella, Antonio Cassone, et al.
AIDS (London, England)|June 29, 2016
Unite forces to validate biomarkers in the quest for lasting HIV remissionCasper Rokx, Stefano Vella, Guiseppe Pantaleo, et al.
Pediatrics|August 3, 2004
Italian attention-deficit/hyperactivity disorder registryPietro Panei, Romano Arcieri, Stefano Vella, et al.
BMC Infectious Diseases|September 2, 2024
The safety of a dolutegravir (DTG)-based antiretroviral treatment (ART) regimen for pregnancy and birth outcomes in Ethiopia: evidence from multicenter cohort studyAbel Gedefaw, Birkneh Tilahun Tadesse, Yifru Berhan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 15, 2018
Economic Evaluation of the Hepatitis C Virus Treatment Extension to Early-Stage Fibrosis Patients: Evidence from the PITER Real-World CohortMatteo Ruggeri, Silvia Coretti, Federica Romano, et al.
AIDS (London, England)|June 19, 2012
The history of antiretroviral therapy and of its implementation in resource-limited areas of the worldStefano Vella, Bernard Schwartländer, Salif Papa Sow, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 26, 2002
In vitro and in vivo modulation of MDR1/P-glycoprotein in HIV-infected patients administered highly active antiretroviral therapy and liposomal doxorubicinMothanje Barbara Lucia, Sergio Rutella, Giuseppe Leone, et al.
Pageof 16